CalciMedica, Inc. (CALC)

CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $13.07 million. The enterprise value is $9.75 million.

Market Cap	13.07M
Enterprise Value	9.75M

Important Dates

The last earnings date was Tuesday, March 3, 2026, before market open.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 15.74 million shares outstanding. The number of shares has increased by 33.48% in one year.

Current Share Class	15.74M
Shares Outstanding	15.74M
Shares Change (YoY)	+33.48%
Shares Change (QoQ)	+5.07%
Owned by Insiders (%)	17.47%
Owned by Institutions (%)	24.73%
Float	9.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.58

Current Ratio	3.58
Quick Ratio	3.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.26

Financial Efficiency

Return on equity (ROE) is -761.02% and return on invested capital (ROIC) is -165.44%.

Return on Equity (ROE)	-761.02%
Return on Assets (ROA)	-86.57%
Return on Invested Capital (ROIC)	-165.44%
Return on Capital Employed (ROCE)	-235.71%
Weighted Average Cost of Capital (WACC)	11.61%
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.77% in the last 52 weeks. The beta is 1.34, so CalciMedica's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-56.77%
50-Day Moving Average	2.45
200-Day Moving Average	2.94
Relative Strength Index (RSI)	38.61
Average Volume (20 Days)	533,459

Short Selling Information

The latest short interest is 391,796, so 2.49% of the outstanding shares have been sold short.

Short Interest	391,796
Short Previous Month	427,832
Short % of Shares Out	2.49%
Short % of Float	4.35%
Short Ratio (days to cover)	0.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.12M
Pretax Income	-29.56M
Net Income	-29.56M
EBITDA	-23.08M
EBIT	-23.12M
Earnings Per Share (EPS)	-$1.97

Balance Sheet

The company has $13.02 million in cash and $9.70 million in debt, with a net cash position of $3.32 million or $0.21 per share.

Cash & Cash Equivalents	13.02M
Total Debt	9.70M
Net Cash	3.32M
Net Cash Per Share	$0.21
Equity (Book Value)	-6.64M
Book Value Per Share	-0.43
Working Capital	9.75M

Cash Flow

In the last 12 months, operating cash flow was -$21.18 million and capital expenditures -$28,000, giving a free cash flow of -$21.21 million.

Operating Cash Flow	-21.18M
Capital Expenditures	-28,000
Free Cash Flow	-21.21M
FCF Per Share	-$1.35

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.48%
Shareholder Yield	-33.48%
Earnings Yield	-226.23%
FCF Yield	-162.28%

Analyst Forecast

The average price target for CalciMedica is $10.00, which is 1,104.82% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	1,104.82%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1